Performance analysis of Skye Bioscience (SKYE)
Annual Return
Over the past 3 years, SKYE has had an average annual return of -39.48%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, SKYE has had an average annual return of -55.74%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, SKYE has had an average annual return of -38.55%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Apr 2, 2015, SKYE has had an average annual return of -48.51%, underperforming the benchmark SPY, which returned +14.24% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -72.73% | +4.76% | -32.26% | -69.31% | +29.49% | -69.29% | -67.31% | +163.39% | -49.66% | -56.88% | -86.41% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +33.33% | -25.00% | -16.67% | +40% | -14.29% | +0% | +0% | ||||||
| 2025 | +13.64% | -12.00% | -45.45% | +41.67% | -11.76% | +113.33% | -12.50% | -3.57% | +14.81% | -61.29% | -16.67% | -40.00% | -72.73% |
| 2024 | +47.62% | +264.52% | +7.08% | -17.36% | -10.00% | -31.11% | -35.48% | +20% | -37.50% | +36.67% | -14.63% | -37.14% | +4.76% |
| 2023 | +109.68% | -7.69% | -43.33% | -23.53% | +11.54% | +41.38% | +9.76% | -22.22% | -8.57% | -56.25% | -7.14% | +61.54% | -32.26% |
| 2022 | -5.94% | -21.05% | -1.33% | -1.35% | +0% | -5.48% | +4.35% | -25.00% | -7.41% | -6.00% | -27.66% | -8.82% | -69.31% |
| 2021 | +87.18% | +54.11% | +2.67% | +1.30% | +14.53% | +16.42% | -3.53% | -9.63% | -25.37% | -31.03% | +9.29% | -33.99% | +29.49% |
| 2020 | +29.92% | -44.24% | -20.65% | +32.88% | -1.03% | +58.85% | -67.87% | -11.22% | -5.75% | -9.76% | -18.92% | +30% | -69.29% |
| 2019 | -20.72% | +54.22% | +41.05% | -2.91% | -25.37% | -42.02% | -1.42% | +10.99% | +16.56% | -18.80% | -26.76% | -40.52% | -67.31% |
| 2018 | +97.63% | -20.07% | -0.86% | +4.98% | +14.02% | -3.07% | -7.28% | -4.23% | +22.48% | +29.85% | +7.79% | -4.78% | +163.39% |
| 2017 | +13.65% | +9.31% | -17.31% | -16.11% | +15.45% | +3.26% | -17.77% | -0% | +1.62% | -45.92% | -13.60% | +25.53% | -49.66% |
Drawdown analysis of Skye Bioscience (SKYE)
The maximum drawdown for the SKYE was -99.96%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current SKYE drawdown is -99.94%.
Since Apr 2, 2015 SKYE has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.96% | Apr 7, 2015 | 2759 | Mar 27, 2026 | Ongoing | Ongoing | Ongoing |